357 related articles for article (PubMed ID: 9701724)
1. Influence of hepatocyte growth factor/scatter factor on the metastatic phenotype of B16 melanoma cells.
Rusciano D; Lin S; Lorenzoni P; Casella N; Burger MM
Tumour Biol; 1998; 19(5):335-45. PubMed ID: 9701724
[TBL] [Abstract][Full Text] [Related]
2. Expression of constitutively activated hepatocyte growth factor/scatter factor receptor (c-met) in B16 melanoma cells selected for enhanced liver colonization.
Rusciano D; Lorenzoni P; Burger MM
Oncogene; 1995 Nov; 11(10):1979-87. PubMed ID: 7478516
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor/scatter factor and hepatocytes are potent downregulators of tyrosinase expression in B16 melanoma cells.
Rusciano D; Lorenzoni P; Lin S; Burger MM
J Cell Biochem; 1998 Nov; 71(2):264-76. PubMed ID: 9779824
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms regulating c-met overexpression in liver-metastatic B16-LS9 melanoma cells.
Elia G; Ren Y; Lorenzoni P; Zarnegar R; Burger MM; Rusciano D
J Cell Biochem; 2001; 81(3):477-87. PubMed ID: 11255230
[TBL] [Abstract][Full Text] [Related]
5. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
[TBL] [Abstract][Full Text] [Related]
6. Murine models of liver metastasis.
Rusciano D; Lorenzoni P; Burger M
Invasion Metastasis; 1994-1995; 14(1-6):349-61. PubMed ID: 7657528
[TBL] [Abstract][Full Text] [Related]
7. C-met activation is necessary but not sufficient for liver colonization by B16 murine melanoma cells.
Lin S; Rusciano D; Lorenzoni P; Hartmann G; Birchmeier W; Giordano S; Comoglio P; Burger MM
Clin Exp Metastasis; 1998 Apr; 16(3):253-65. PubMed ID: 9568643
[TBL] [Abstract][Full Text] [Related]
8. Paracrine growth response as a major determinant in liver-specific colonization by in vivo selected B16 murine melanoma cells.
Rusciano D; Lorenzoni P; Burger MM
Invasion Metastasis; 1993; 13(4):212-24. PubMed ID: 8034443
[TBL] [Abstract][Full Text] [Related]
9. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).
Hendrix MJ; Seftor EA; Seftor RE; Kirschmann DA; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
Am J Pathol; 1998 Apr; 152(4):855-63. PubMed ID: 9546344
[TBL] [Abstract][Full Text] [Related]
10. Constitutive c-Met signaling through a nonautocrine mechanism promotes metastasis in a transgenic transplantation model.
Yu Y; Merlino G
Cancer Res; 2002 May; 62(10):2951-6. PubMed ID: 12019177
[TBL] [Abstract][Full Text] [Related]
11. Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor.
Ried S; Jäger C; Jeffers M; Vande Woude GF; Graeff H; Schmitt M; Lengyel E
J Biol Chem; 1999 Jun; 274(23):16377-86. PubMed ID: 10347197
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells.
Moriyama T; Kataoka H; Hamasuna R; Yoshida E; Sameshima T; Iseda T; Yokogami K; Nakano S; Koono M; Wakisaka S
Clin Exp Metastasis; 1999; 17(10):873-9. PubMed ID: 11089886
[TBL] [Abstract][Full Text] [Related]
13. A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation.
Anastasi S; Giordano S; Sthandier O; Gambarotta G; Maione R; Comoglio P; Amati P
J Cell Biol; 1997 Jun; 137(5):1057-68. PubMed ID: 9166406
[TBL] [Abstract][Full Text] [Related]
14. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
15. Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.
Paciucci R; Vilá MR; Adell T; Díaz VM; Torà M; Nakamura T; Real FX
Am J Pathol; 1998 Jul; 153(1):201-12. PubMed ID: 9665481
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
Recio JA; Merlino G
Cancer Res; 2003 Apr; 63(7):1576-82. PubMed ID: 12670907
[TBL] [Abstract][Full Text] [Related]
17. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.
Abounader R; Ranganathan S; Lal B; Fielding K; Book A; Dietz H; Burger P; Laterra J
J Natl Cancer Inst; 1999 Sep; 91(18):1548-56. PubMed ID: 10491431
[TBL] [Abstract][Full Text] [Related]
18. Paracrine effects of hepatocyte growth factor/scatter factor on non-small-cell lung carcinoma cell lines.
Yi S; Chen JR; Viallet J; Schwall RH; Nakamura T; Tsao MS
Br J Cancer; 1998 Jun; 77(12):2162-70. PubMed ID: 9649128
[TBL] [Abstract][Full Text] [Related]
19. [Influence of scatter factor/hepatocyte growth factor on the growth and transmission of hepatocarcinoma SMMC 7721 cells].
Xie Q; Liu K; Hu M; Wu X; Zhou K
Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):95-7. PubMed ID: 11350688
[TBL] [Abstract][Full Text] [Related]
20. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor.
Naldini L; Tamagnone L; Vigna E; Sachs M; Hartmann G; Birchmeier W; Daikuhara Y; Tsubouchi H; Blasi F; Comoglio PM
EMBO J; 1992 Dec; 11(13):4825-33. PubMed ID: 1334458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
